Discontinued Operations (Details 2) (USD $) In Millions, unless otherwise specified	1 Months Ended	12 Months Ended
	Jul. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Current assets held for disposition		$ 892	$ 438
Current liabilities held for disposition		680	386
Non-current liabilities held for disposition		108	7
Developed markets branded generics pharmaceuticals business
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc	110
Period of notice require to terminate manufacturing supply of products		2 years
Trade receivables, net		498	163
Total inventories		254	243
Prepaid expenses, deferred income taxes, and other receivables		140	32
Current assets held for disposition		892	438
Net property and equipment		125	28
Intangible assets, net of amortization		804
Goodwill		950
Deferred income taxes and other assets		55	38
Non-current assets held for disposition		1,934	66
Total assets held for disposition		2,826	504
Trade accounts payable		423	285
Salaries, wages, commissions and other accrued liabilities		257	101
Current liabilities held for disposition		680	386
Post-employment obligations, deferred income taxes and other long-term liabilities		108	7
Total liabilities held for disposition		$ 788	$ 393
Developed markets branded generics pharmaceuticals business | Minimum
Period for providing manufacturing supply of products		3 years
Developed markets branded generics pharmaceuticals business | Maximum
Period of transition services		2 years
Period for providing manufacturing supply of products		10 years